Pharmaceutical formulations containing solubilized hydroquinone, salicylic acid and hydrocortisone for the treatment of melasma and related dermatological problems
AssigneeLila Gruber Research Foundation
InventorMurray Gruber
Life of this patent
Estimating the term…
Abstract
Abstract of the Disclosure There are provided dermatological compositions achieved by combining solubilized, stabilized hydroquinone salicylic acid and hydrocortisone by dissolving the three ingredents in dimethyl isosorbide. These preparations are intended for the treatment of melasma and related disorders of the skin such as freckles, senile lentigines, chloasma, ultraviolet induced dyschromia and discoloration resulting from ingestion of oral contraceptives or hormonal replacement therapy.
Claims13
A topical pharmaceutical formulation for treating a patient suffering from melasma and related dermatological conditions comprising an amount of solubilized, stabilized hydroquinone effective to treat said conditions.
A pharmaceutical formulation for treating a patient suffering from melasma and related dermatological conditions comprising hydroquinone, salicylic acid and hydrocortisone, wherein the hydroquinone, salicylic acid and hydrocortisone are solubilized and stabilized and in combination are effective to treat said conditions.
Dependencies are inferred from the claim text.